Descrizione del progetto
Screening innovativo del carcinoma della cervice uterina
Il tumore della cervice uterina è una delle cause di mortalità per cancro nelle donne e più di un quarto delle pazienti proviene dai paesi in via di sviluppo. Per ridurre l’incidenza e la mortalità di tale carcinoma, lo screening è fondamentale. Il progetto PRESCRIP-TEC, finanziato dall’UE, propone un innovativo screening per il carcinoma della cervice uterina che include un trattamento diretto e il follow-up per donne nei paesi a reddito medio e per gruppi vulnerabili in Europa orientale. Il progetto eseguirà ricerche sull’implementazione in diverse aree di Bangladesh, India, Slovacchia e Uganda, analizzando gli elementi facilitatori e gli ostacoli per pazienti e servizi sanitari relativi all’adozione dello screening del carcinoma della cervice. PRESCRIP-TEC introdurrà informazioni interattive condivise con le comunità tramite dispositivi mobili e social media, strategie amichevoli basate sulla comunità, autotest per l’infezione da HPV ad alto rischio e tecnologie di intelligenza artificiale nel corso delle visite ginecologiche.
Obiettivo
The proposed Prevention and Screening Innovation Project towards Elimination of Cervical Cancer (PRESCRIP-TEC) will lead to effective and innovative cervical cancer screening, including direct treatment and follow-up for women in resource-poor or hard-to-reach settings in the world, by improving availability, accessibility, acceptability and quality of services. PRESCRIP-TEC will conduct implementation research into cervical cancer screening and secondary prevention in different settings in four countries over three continents: Bangladesh and India in Asia, Uganda in Africa, and Slovakia in Eastern Europe. We will analyse patient- and health services-related facilitators and barriers for uptake of cervical cancer screening in low- and middle-income countries and in vulnerable groups in Eastern Europe. By taking existing screening protocols in the four countries, we will introduce 1) interactive information with communities via mobile devices and social media; 2) client-friendly, community-based strategies, with self-test for high risk HPV infection; and 3) artificial intelligence in gynaecological examination. The use of artificial intelligence built into mobile devices offers a future for high quality diagnostics in resource-poor settings. By doing so, we will reduce the number of physical examinations and implement screenings by lower-level trained cadres. In addition, through a cost-effectiveness analysis and a business case for the global introduction of hrHPV testing as routine screening for cervical cancer, we will show the advantage of point-of-delivery testing and the benefits of self-testing for cancer in the post-COVID era, which reduces pressure on the health system. PRESCRIP-TEC will strengthen evidence of innovative strategies for cervical cancer screening as advocated by the World Health Organization and will contribute to eradication of cervical cancer worldwide through prevention and early diagnosis, alleviating the global burden of cancer.
Campo scientifico
Parole chiave
Programma(i)
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SC1-2020-Single-Stage-RTD
Meccanismo di finanziamento
RIA - Research and Innovation actionCoordinatore
9713 GZ Groningen
Paesi Bassi